Quick Takeaways
- Matthew Angel has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $38,112,971.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Matthew Angel
- Location
- San Diego, CA
- Summary
- The estimated net worth of Matthew Angel is at least $38,112,971 dollars as of 25 Mar 2026. Matthew Angel is the CEO and President, Director, 10%+ Owner of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $38.11M.
- Signature
- /s/ Matthew Angel
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Matthew Angel and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Tempest Therapeutics, Inc. ($38,112,971).
- Past-year value change for that position: +$500,001.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Matthew Angel
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | CEO and President, Director, 10%+ Owner | $38,112,971 | +$500,001 | +1.3% | 24 Mar 2026 |
| ERNA, ERNAW | Eterna Therapeutics Inc. | President and CEO, Director | 12 Jan 2023 |
Insider Transactions Reported by Matthew Angel:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.